{
    "root": "519db8a9-48ab-4826-a2b3-6d67d6a24017",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "WYMZYA Fe",
    "value": "20250514",
    "ingredients": [],
    "indications": {
        "text": "wymzya tm fe indicated females reproductive potential prevent pregnancy .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "take one tablet mouth time every day . tablets may chewed swallowed . ( 2.1 ) take tablets order directed blister . ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "wymzya fe [ norethindrone ethinyl estradiol tablets usp ( chewable ) ferrous fumarate tablets ] available blister pack ( ndc 68180-873-71 ) containing 28 tablets packed pouch ( ndc 68180-873-71 ) . three pouches packaged carton ( ndc 68180-873-73 ) . blister contains 28 tablets following order : 21 white off-white , round ( active ) , flat face , beveled edge tablets debossed `` lu `` one side `` m21 `` side containing 0.4 mg norethindrone 35 mcg ethinyl estradiol . 7 brown , mottled , round ( non-hormonal placebo ) , flat face , beveled edge tablets debossed `` lu `` one side `` m22 `` side containing 75 mg ferrous fumarate .",
    "adverseReactions": "wymzya fe contraindicated females known develop following conditions : high risk arterial venous thrombotic diseases . examples include women known : smoke , age 35 [ boxed warning ( 5.1 ) ] deep vein thrombosis pulmonary embolism , past [ ( 5.1 ) ] inherited acquired hypercoagulopathies [ ( 5.1 ) ] cerebrovascular disease [ ( 5.1 ) ] coronary artery disease [ ( 5.1 ) ] thrombogenic valvular thrombogenic rhythm diseases heart ( example , subacute bacterial endocarditis valvular disease , atrial fibrillation ) [ ( 5.1 ) ] uncontrolled hypertension [ ( 5.4 ) ] diabetes mellitus vascular disease [ ( 5.6 ) ] headaches focal neurological symptoms migraine headaches aura [ ( 5.7 ) ]",
    "indications_original": "WYMZYA\n                        TM\n                      Fe is indicated for use by females of reproductive potential to prevent pregnancy.",
    "contraindications_original": "Take one tablet by mouth at the same time every day. Tablets may be chewed or swallowed. ( 2.1 ) Take tablets in the order directed on the blister .( 2.1 )",
    "warningsAndPrecautions_original": "WYMZYA Fe [norethindrone and ethinyl estradiol tablets USP (chewable) and ferrous fumarate tablets] is available in a blister pack (NDC 68180-873-71) containing 28 tablets packed in a pouch (NDC 68180-873-71). Such three pouches are packaged in a carton (NDC 68180-873-73).\n                        Each blister contains 28 tablets in the following order:\n                        \n                           21 white to off-white, round (active), flat face, beveled edge      tablets debossed with \"LU\" on one side and \"M21\" on the other      side and each containing 0.4 mg norethindrone and 35 mcg ethinyl      estradiol.\n                           7 brown, mottled, round (non-hormonal placebo), flat face, beveled      edge tablets debossed with \"LU\" on one side and \"M22\" on the      other side and each containing 75 mg ferrous fumarate.",
    "adverseReactions_original": "WYMZYA Fe is contraindicated in females who are known to have or develop the following conditions:\n                  \n                     A high risk of      arterial or venous thrombotic diseases. Examples include women who are      known to:\n                           Smoke, if over      age 35 [see BOXED WARNING and WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have deep vein      thrombosis or pulmonary embolism, now or in the past [see WARNINGS AND      PRECAUTIONS (5.1)]\n                           \n                           Have inherited      or acquired hypercoagulopathies [see WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have      cerebrovascular disease [see WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have coronary      artery disease [see WARNINGS AND PRECAUTIONS      (5.1)]\n                           \n                           Have      thrombogenic valvular or thrombogenic rhythm diseases of the heart (for      example, subacute bacterial endocarditis with valvular disease, or atrial      fibrillation) [see WARNINGS AND PRECAUTIONS (5.1)]\n                           \n                           Have      uncontrolled hypertension [see WARNINGS AND PRECAUTIONS      (5.4)]\n                           \n                           Have diabetes      mellitus with vascular disease [see WARNINGS AND PRECAUTIONS      (5.6)]\n                           \n                           Have headaches      with focal neurological symptoms or have migraine headaches with aura [see      WARNINGS AND PRECAUTIONS (5.7)]",
    "drug": [
        {
            "name": "WYMZYA Fe"
        }
    ]
}